de BlackRock Sabra Healthcare REIT SBRA Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 812 M | Comprar |
41,614,351
+2,515,962
| +6% | +USD 49.9 M | 0.01% | 889 |
|
|
2026
Q1 | USD 752 M | Comprar |
39,098,389
+704,770
| +2% | +USD 13.9 M | 0.01% | 841 |
|
|
2025
Q4 | USD 727 M | Comprar |
38,393,619
+1,291,591
| +3% | +USD 23.9 M | 0.01% | 854 |
|
|
2025
Q3 | USD 692 M | Comprar |
37,102,028
+690,324
| +2% | +USD 12.9 M | 0.01% | 876 |
|
|
2025
Q2 | USD 671 M | Vender |
36,411,704
-2,448,797
| -6% | -USD 43.5 M | 0.01% | 853 |
|
|
2025
Q1 | USD 679 M | Comprar |
38,860,501
+1,840,162
| +5% | +USD 31 M | 0.01% | 834 |
|
|
2024
Q4 | USD 641 M | Comprar |
37,020,339
+1,423,019
| +4% | +USD 26 M | 0.01% | 918 |
|
|
2024
Q3 | USD 662 M | Comprar |
35,597,320
+1,210,446
| +4% | +USD 20.4 M | 0.01% | 875 |
|
|
2024
Q2 | USD 530 M | Comprar |
34,386,874
+188,609
| +0.6% | +USD 2.7 M | 0.01% | 965 |
|
|
2024
Q1 | USD 505 M | Vender |
34,198,265
-269,944
| -0.8% | -USD 3.74 M | 0.01% | 1029 |
|
|
2023
Q4 | USD 492 M | Comprar |
34,468,209
+1,139,125
| +3% | +USD 16.2 M | 0.01% | 1026 |
|
|
2023
Q3 | USD 465 M | Comprar |
33,329,084
+180,359
| +0.5% | +USD 2.31 M | 0.01% | 948 |
|
|
2023
Q2 | USD 390 M | Comprar |
33,148,725
+486,114
| +1% | +USD 5.53 M | 0.01% | 1111 |
|
|
2023
Q1 | USD 376 M | Vender |
32,662,611
-69,582
| -0.2% | -USD 861 k | 0.01% | 1111 |
|
|
2022
Q4 | USD 407 M | Comprar |
32,732,193
+655,198
| +2% | +USD 8.35 M | 0.01% | 1024 |
|
|
2022
Q3 | USD 421 M | Vender |
32,076,995
-398,115
| -1% | -USD 5.88 M | 0.01% | 918 |
|
|
2022
Q2 | USD 454 M | Comprar |
32,475,110
+11,626
| +0% | +USD 155 k | 0.01% | 920 |
|
|
2022
Q1 | USD 483 M | Vender |
32,463,484
-741,115
| -2% | -USD 10.1 M | 0.01% | 1011 |
|
|
2021
Q4 | USD 450 M | Comprar |
33,204,599
+2,066,288
| +7% | +USD 29.2 M | 0.01% | 1107 |
|
|
2021
Q3 | USD 458 M | Comprar |
31,138,311
+59,098
| +0.2% | +USD 998 k | 0.01% | 1050 |
|
|
2021
Q2 | USD 566 M | Comprar |
31,079,213
+637,071
| +2% | +USD 11.3 M | 0.02% | 930 |
|
|
2021
Q1 | USD 528 M | Comprar |
30,442,142
+1,292,607
| +4% | +USD 22.7 M | 0.02% | 954 |
|
|
2020
Q4 | USD 506 M | Comprar |
29,149,535
+919,957
| +3% | +USD 14.7 M | 0.02% | 885 |
|
|
2020
Q3 | USD 389 M | Vender |
28,229,578
-452,937
| -2% | -USD 6.65 M | 0.01% | 895 |
|
|
2020
Q2 | USD 414 M | Vender |
28,682,515
-458,418
| -2% | -USD 6.03 M | 0.02% | 837 |
|
|
2020
Q1 | USD 318 M | Comprar |
29,140,933
+1,419,838
| +5% | +USD 26.2 M | 0.02% | 863 |
|
|
2019
Q4 | USD 592 M | Comprar |
27,721,095
+1,101,341
| +4% | +USD 24.7 M | 0.02% | 699 |
|
|
2019
Q3 | USD 611 M | Comprar |
26,619,754
+1,341,510
| +5% | +USD 28.6 M | 0.03% | 629 |
|
|
2019
Q2 | USD 498 M | Vender |
25,278,244
-251,661
| -1% | -USD 4.9 M | 0.02% | 744 |
|
|
2019
Q1 | USD 497 M | Comprar |
25,529,905
+63,064
| +0.2% | +USD 1.2 M | 0.02% | 737 |
|
|
2018
Q4 | USD 420 M | Vender |
25,466,841
-108,007
| -0.4% | -USD 2.17 M | 0.02% | 748 |
|
|
2018
Q3 | USD 591 M | Comprar |
25,574,848
+34,048
| +0.1% | +USD 771 k | 0.03% | 663 |
|
|
2018
Q2 | USD 555 M | Vender |
25,540,800
-606,028
| -2% | -USD 11.8 M | 0.03% | 665 |
|
|
2018
Q1 | USD 461 M | Comprar |
26,146,828
+577,060
| +2% | +USD 10.2 M | 0.02% | 749 |
|
|
2017
Q4 | USD 480 M | Comprar |
25,569,768
+1,673,758
| +7% | +USD 33.3 M | 0.02% | 728 |
|
|
2017
Q3 | USD 524 M | Comprar |
23,896,010
+14,325,578
| +150% | +USD 324 M | 0.03% | 635 |
|
|
2017
Q2 | USD 231 M | Comprar |
9,570,432
+277,421
| +3% | +USD 7.05 M | 0.01% | 1177 |
|
|
2017
Q1 | USD 260 M | Comprar |
9,293,011
+9,193,585
| +9,247% | +USD 241 M | 0.01% | 1075 |
|
|
2016
Q4 | USD 2.43 M | Comprar |
99,426
+12,711
| +15% | +USD 291 k | ﹤0.01% | 1157 |
|
|
2016
Q3 | USD 2.18 M | Comprar |
86,715
+5,327
| +7% | +USD 128 k | ﹤0.01% | 1173 |
|
|
2016
Q2 | USD 1.68 M | Comprar |
81,388
+18,548
| +30% | +USD 387 k | ﹤0.01% | 1235 |
|
|
2016
Q1 | USD 1.26 M | Comprar |
62,840
+5,433
| +9% | +USD 104 k | ﹤0.01% | 1276 |
|
|
2015
Q4 | USD 1.16 M | Vender |
57,407
-197
| -0.3% | -USD 4.15 k | ﹤0.01% | 1261 |
|
|
2015
Q3 | USD 1.34 M | Comprar |
57,604
+5,065
| +10% | +USD 129 k | ﹤0.01% | 1185 |
|
|
2015
Q2 | USD 1.35 M | Vender |
52,539
-4,940
| -9% | -USD 140 k | ﹤0.01% | 1244 |
|
|
2015
Q1 | USD 1.9 M | Comprar |
57,479
+9,261
| +19% | +USD 301 k | ﹤0.01% | 1102 |
|
|
2014
Q4 | USD 1.46 M | Comprar |
48,218
+5,634
| +13% | +USD 155 k | ﹤0.01% | 1124 |
|
|
2014
Q3 | USD 1.04 M | Comprar |
42,584
+2,753
| +7% | +USD 76.3 k | ﹤0.01% | 1203 |
|
|
2014
Q2 | USD 1.14 M | Comprar |
39,831
+9,991
| +33% | +USD 290 k | ﹤0.01% | 1166 |
|
|
2014
Q1 | USD 832 k | Comprar |
29,840
+1,319
| +5% | +USD 36.2 k | ﹤0.01% | 1244 |
|
|
2013
Q4 | USD 745 k | Comprar |
28,521
+4,910
| +21% | +USD 127 k | ﹤0.01% | 1245 |
|
|
2013
Q3 | USD 543 k | Comprar |
23,611
+2,706
| +13% | +USD 66.7 k | ﹤0.01% | 1235 |
|
|
2013
Q2 | USD 545 k | Comprar |
+20,905
| Nuevas | +USD 603 k | ﹤0.01% | 1202 |
|
Otros fondos que tienen SBRA en su cartera
Posición de BlackRock en SBRA: resumen de T2 2026
BlackRock aumentó su participación en Sabra Healthcare REIT (SBRA) en 6.4% durante T2 2026, al comprar aproximadamente USD 49.9 M y elevar la posición a 41,614,351 acciones con un valor de USD 812 M. La posición representa 0.01% de la cartera y ocupa el puesto #889.
BlackRock reportó por primera vez una posición en SBRA en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 466 fondos que sigue Wall St. Rank mantienen una posición en SBRA.
- Al cierre de T2 2026, BlackRock tenía 41,614,351 acciones de Sabra Healthcare REIT con un valor de USD 812 M.
- BlackRock compró 2,515,962 acciones de Sabra Healthcare REIT en T2 2026, por un monto estimado de USD 49.9 M.
- Sabra Healthcare REIT representó 0.01% de la cartera de BlackRock en T2 2026 y fue su posición número 889.
- BlackRock reportó por primera vez una posición en Sabra Healthcare REIT en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 466 fondos que sigue Wall St. Rank tenían Sabra Healthcare REIT en cartera.
Según el Informe 13F de BlackRock correspondiente a T2 2026, presentado el 7 ago 2026.